Kiarash Kojouri

1.4k total citations
22 papers, 952 citations indexed

About

Kiarash Kojouri is a scholar working on Hematology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Kiarash Kojouri has authored 22 papers receiving a total of 952 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 5 papers in Immunology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Kiarash Kojouri's work include Platelet Disorders and Treatments (6 papers), Complement system in diseases (5 papers) and Blood groups and transfusion (5 papers). Kiarash Kojouri is often cited by papers focused on Platelet Disorders and Treatments (6 papers), Complement system in diseases (5 papers) and Blood groups and transfusion (5 papers). Kiarash Kojouri collaborates with scholars based in United States. Kiarash Kojouri's co-authors include James N. George, Sara K. Vesely, Deirdra R. Terrell, James N. George, Jedidiah J. Perdue, Robert D. Woodson, Joseph E. Kiss, George B. Selby, Zoltán Lászik and Karen K. Swisher and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Internal Medicine.

In The Last Decade

Kiarash Kojouri

21 papers receiving 923 citations

Peers

Kiarash Kojouri

HEMAT

NEPHR

IMMUN

SURGE

PFM

Giacomo Quattrocchio Italy

Lise Thibaudin France

Susan Y. Woodford United States

Jennifer M. Bird United Kingdom

Sandra Fátima Menosi Gualandro Brazil

Carlos Chiurchiu Argentina

Etsuji Suehisa Japan

B. Hartley United Kingdom

Olga Meltem Akay Türkiye

GP Herzig United States

Giacomo Quattrocchio Italy

Kiarash Kojouri

158 ×0.2

HEMAT

421 ×1.5

NEPHR

115 ×0.4

IMMUN

115 ×0.6

SURGE

94 ×0.5

PFM

Citations per year, relative to Kiarash Kojouri Kiarash Kojouri (= 1×) peers Giacomo Quattrocchio

Countries citing papers authored by Kiarash Kojouri

Since Specialization

Citations

This map shows the geographic impact of Kiarash Kojouri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kiarash Kojouri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kiarash Kojouri more than expected).

Fields of papers citing papers by Kiarash Kojouri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kiarash Kojouri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kiarash Kojouri. The network helps show where Kiarash Kojouri may publish in the future.

Co-authorship network of co-authors of Kiarash Kojouri

This figure shows the co-authorship network connecting the top 25 collaborators of Kiarash Kojouri. A scholar is included among the top collaborators of Kiarash Kojouri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kiarash Kojouri. Kiarash Kojouri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Budde, Lihua E., David Wu, Daniel B. Martin, et al.. (2018). Bendamustine with rituximab, etoposide and carboplatin (T(R)EC) in relapsed or refractory aggressive lymphoma: a prospective multicentre phase 1/2 clinical trial. British Journal of Haematology. 183(4). 601–607. 7 indexed citations

Shadman, Mazyar, Ajay K. Gopal, Oliver W. Press, et al.. (2016). Fludarabine, Cyclophosphamide, Rituximab (FCR) and Vorinostat Followed By Rituximab and Vorinostat Maintenance Therapy in Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL) - Final Results of a Phase I/II Study. Blood. 128(22). 4396–4396. 1 indexed citations

Mawad, Raya, Ajay K. Gopal, Oliver W. Press, et al.. (2013). A Phase I/II Study Of Fludarabine, Cyclophosphamide, Rituximab and Vorinostat Followed By Rituximab and Vorinostat Maintenance Therapy In Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia (CLL) Or Small Lymphocytic Leukemia (SLL). Blood. 122(21). 4191–4191. 2 indexed citations

Kojouri, Kiarash, et al.. (2008). Thrombotic Microangiopathy After Allogeneic Hematopoietic Stem Cell Transplantation: An Autopsy Study. Transplantation. 85(1). 22–28. 71 indexed citations

Krempl, Greg A., et al.. (2008). Treatment of Base of Tongue Cancer With Paclitaxel, Ifosfamide, and Cisplatinum Induction Chemotherapy Followed by Chemoradiotherapy. The Laryngoscope. 118(8). 1357–1361. 12 indexed citations

Tfayli, Arafat, et al.. (2008). Neoadjuvant therapy with celecoxib to women with early stage breast cancer.. PubMed. 55(2). 122–6. 6 indexed citations

Ansari, Rafat, Mark A. Socinski, J. K. Choksi, et al.. (2008). A phase II, multicenter evaluation of docetaxel, gemcitabine, and bevacizumab followed by bevacizumab alone in patients with locally advanced or metastatic non-small cell lung cancer (central localization excluded). Journal of Clinical Oncology. 26(15_suppl). 19077–19077.

Kojouri, Kiarash & James N. George. (2007). Thrombotic microangiopathy following allogeneic hematopoietic stem cell transplantation. Current Opinion in Oncology. 19(2). 148–154. 33 indexed citations

George, James N., Robert D. Woodson, Joseph E. Kiss, Kiarash Kojouri, & Sara K. Vesely. (2006). Rituximab therapy for thrombotic thrombocytopenic purpura: A proposed study of the Transfusion Medicine/Hemostasis Clinical Trials Network with a systematic review of rituximab therapy for immune‐mediated disorders. Journal of Clinical Apheresis. 21(1). 49–56. 80 indexed citations

10.

Kharfan‐Dabaja, Mohamed A., Samit Patel, Adeboye O. Osunkoya, et al.. (2006). Expression of the vascular endothelial growth factor receptors 1 and 2 in acute myeloid leukemia: incidence and feasibility of immunohistochemical staining. Clinical & Laboratory Haematology. 28(4). 254–258. 7 indexed citations

11.

Kojouri, Kiarash, et al.. (2006). Trisomy 1q in a patient with severe aplastic anemia. Cancer Genetics and Cytogenetics. 169(1). 73–75. 6 indexed citations

12.

Kojouri, Kiarash & James N. George. (2005). Recent Advances in the Treatment of Chronic Refractory Immune Thrombocytopenic Purpura. International Journal of Hematology. 81(2). 119–125. 10 indexed citations

13.

Kojouri, Kiarash, et al.. (2005). Occult systemic malignancy masquerading as thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Community Oncology. 2(4). 339–343. 15 indexed citations

14.

Kojouri, Kiarash, Jian Yang, Sunil V. Patel, et al.. (2004). Prognostic Significance of BCL-2 Expression in Patients with Multiple Myeloma.. Blood. 104(11). 4840–4840. 1 indexed citations

15.

Kojouri, Kiarash, Sara K. Vesely, Deirdra R. Terrell, & James N. George. (2004). Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. Blood. 104(9). 2623–2634. 469 indexed citations

16.

Kojouri, Kiarash, et al.. (2004). Prognostic significance of VEGF receptor I and II expression in patients with acute myeloid leukemia. Journal of Clinical Oncology. 22(14_suppl). 9623–9623. 1 indexed citations

17.

Rizvi, Mujahid A., Kiarash Kojouri, & James N. George. (2001). Drug-Induced Thrombocytopenia: An Updated Systematic Review. Annals of Internal Medicine. 134(4). 346–346. 30 indexed citations

18.

Kojouri, Kiarash, Sara K. Vesely, & James N. George. (2001). Quinine-Associated Thrombotic Thrombocytopenic Purpura–Hemolytic Uremic Syndrome: Frequency, Clinical Features, and Long-Term Outcomes. Annals of Internal Medicine. 135(12). 1047–1051. 97 indexed citations

19.

George, James N., Kiarash Kojouri, Jedidiah J. Perdue, & Sara K. Vesely. (2000). Management of patients with chronic, refractory idiopathic thrombocytopenic purpura. Seminars in Hematology. 37(3). 290–298. 48 indexed citations

20.

Kojouri, Kiarash, Jedidiah J. Perdue, Patrick J. Medina, & James N. George. (2000). Occult quinine-induced thrombocytopenia.. PubMed. 93(11). 519–21. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact